Integrative analysis of ASXL family genes reveals ASXL2 as an immunoregulatory molecule in head and neck squamous cell carcinoma

Integrative analysis of ASXL family genes reveals ASXL2 as an immunoregulatory molecule in head and neck squamous cell carcinoma

Abstract Despite the progress in conventional treatments for head and neck squamous cell carcinoma (HNSCC), the 5-year survival rate remains below 70%. Enhancing immunotherapy outcomes through personalized treatment strategies, particularly by identifying immune-related biomarkers, is critical. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Liu, Wenhao Zhu, Chenpeng Tang, Wenbin Liu, Xiangjian Luo
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Head and neck squamous cell carcinoma
ASXL2
Prognosis
Immunotherapy
Immunoregulation
Online Access:https://doi.org/10.1038/s41598-024-82815-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-82815-8

Similar Items